GURUFOCUS.COM » STOCK LIST » USA » OTCPK » THC Therapeutics Inc (OTCPK:THCT) » Definitions » EV-to-FCF
Switch to:

THC Therapeutics (OTCPK:THCT) EV-to-FCF

: -3.38 (As of Today)
View and export this data going back to 2007. Start your Free Trial

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, THC Therapeutics's Enterprise Value is $1.42 Mil. THC Therapeutics's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2022 was $-0.42 Mil. Therefore, THC Therapeutics's EV-to-FCF for today is -3.38.

The historical rank and industry rank for THC Therapeutics's EV-to-FCF or its related term are showing as below:

THCT' s EV-to-FCF Range Over the Past 10 Years
Min: -12.94   Med: 0   Max: 0
Current: -6.79

THCT's EV-to-FCF is ranked worse than
100% of 498 companies
in the Drug Manufacturers industry
Industry Median: 23.01 vs THCT: -6.79

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2022-12-09), THC Therapeutics's stock price is $0.06. THC Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2022 was $-0.050. Therefore, THC Therapeutics's PE Ratio for today is At Loss.


THC Therapeutics (OTCPK:THCT) EV-to-FCF Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, THC Therapeutics's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

THC Therapeutics (OTCPK:THCT) EV-to-FCF Distribution

For the Drug Manufacturers industry and Healthcare sector, THC Therapeutics's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where THC Therapeutics's EV-to-FCF falls into.



THC Therapeutics EV-to-FCF Calculation

THC Therapeutics's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1.416/-0.419
=-3.38

THC Therapeutics's current Enterprise Value is $1.42 Mil.
THC Therapeutics's Free Cash Flow for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.42 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


THC Therapeutics  (OTCPK:THCT) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

THC Therapeutics's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.06/-0.050
=At Loss

THC Therapeutics's share price for today is $0.06.
THC Therapeutics's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jul. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.050.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


THC Therapeutics EV-to-FCF Related Terms

Thank you for viewing the detailed overview of THC Therapeutics's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


THC Therapeutics (OTCPK:THCT) Business Description

THC Therapeutics logo
Traded in Other Exchanges
N/A
Address
11700 W Charleston Bpulevard, Suite 73, Las Vegas, NV, USA, 89135
THC Therapeutics Inc is a United States-based company. It is focused on developing dHydronator, a sanitizing herb dryer. The main function of the dHydronator is to accelerate the drying time of an herb while sanitizing it. The dHydronator can be used to dry a variety of herbs, and it has been specifically tested for use with cannabis. It will reduce the drying time for cannabis from 10-14 days down to less than 14 hours while reducing the viability of microbial contaminants.
Executives
Tanaka Hiro director, officer: Vice President 3RD FLOOR, 207 REGENT STREET LONDON X0 W1B 3HH
Smith Adrian J R director, officer: Chair of the Board 119 SPRINGLINE DRIVE VERO BEACH FL 32963
Mann Jamie director, 10 percent owner, officer: CEO, CFO 3RD FLOOR, 207 REGENT STREET LONDON X0 W1B 3HH
Ho Eden director, officer: CEO 701 XUANG MI HU ROAD, XI YUAN, FUTIAN SHENZHEN F4 XXXXXX
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
premium membership